• CAT Number: I005184
  • CAS Number: 863971-12-4
  • Molecular Formula: C40H67N5O8
  • Molecular Weight: 745.99
  • Purity: ≥95%
Inquiry Now

<p style=/line-height:25px/>MMAF-OMe inhibits several tumor cell lines with IC50s of 0.056 nM, 0.166 nM, 0.183 nM, and 0.449 nM for MDAMB435/5T4, MDAMB361DYT2, MDAMB468, and Raji (5T4-) cell lines, respectively.<br>IC50:<br>Target:tubulin<br>In vitro:<br>In vivo: 2.5F-Fc and 2.5F-Fc-MMAF have similar IC50 values (6.9 ± 1.1 vs. 8.3 ± 1.3 nmol/L, respectively), indicating that MMAF conjugation has negligible impact on integrin-binding affinity[1].</p>

Catalog Number I005184
CAS Number 863971-12-4
Molecular Formula


Purity 95%
Target tubulin
Solubility DMSO
Storage -20°C

<p style=/line-height:25px/>
<br>[1]. Currier NV, et al. Targeted Drug Delivery with an Integrin-Binding Knottin-Fc-MMAF Conjugate Produced by Cell-Free Protein Synthesis. Mol Cancer Ther. 2016 Jun;15(6):1291-300.

<br>[2]. Stephan JP, et al. Anti-CD22-MCC-DM1 and MC-MMAF conjugates: impact of assay format on pharmacokinetic parameters determination. Bioconjug Chem. 2008 Aug;19(8):1673-83.

<br>[3]. Wils J, et al. MMAF for advanced gastric cancer. Eur J Cancer. 1992;28A(6-7):1299.

<br>[4]. Anderson H, et al. MMAF for advanced gastric cancer. Eur J Cancer. 1991;27(10):1234-8.


Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!